BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SILVAPHL

All Eps Dividend Board Agm Q1 Q2 Q3

SILVAPHL 14-Nov-2018

(Q1 Un-audited): EPS was Tk. 0.48 for July-September, 2018 as against Tk. 0.21 for July-September, 2017; NOCFPS was Tk. 0.18 for July-September, 2018 as against Tk. 0.30 for July-September, 2017. NAV per share was Tk. 15.79 as on September 30, 2018 and Tk. 17.11 as on June 30, 2018.

SILVAPHL 12-Nov-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2018 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2018.

SILVAPHL 10-Oct-2018

(Continuation news of SILVAPHL): On the other hand, NAV per share (considering Pre-IPO paid up shares) was Tk. 17.11 as on 30 June 2018 and the same would be Tk. 15.47 (considering Post-IPO paid up shares). Weighted average Pre-IPO paid-up number of shares was 100,000,000 for the year ended on 30 June 2018 and 77,818,082 for the year ended on 30 June 2017. Post-IPO number of paid-up shares would be 130,000,000. (end)

SILVAPHL 10-Oct-2018

Silva Pharmaceuticals Limited: As per audited annual financial statements, Profit after tax was Tk. 92.99 million and basic EPS was Tk. 0.93 for the year ended on 30 June 2018 as against profit after tax of Tk. 80.28 million and basic EPS of Tk. 1.03 for the previous year ended on 30 June 2017. However, Post-IPO basic EPS for the year ended on 30 June 2018 would be Tk. 0.72. (cont.)

SILVAPHL 10-Oct-2018

DSE NEWS: The Stock Brokers, Merchant Bankers and Portfolio Managers are requested to abstain from providing loan facilities to purchase securities of Silva Pharmaceuticals Limited in between 1st to 30th trading day starting from today i.e. October 10, 2018 as per BSEC Directive No. SEC/CMRRCD/2009-193/177 and BSEC Order No. SEC/CMRRCD/2009-193/178 dated October 27, 2015.

SILVAPHL 10-Oct-2018

Trading of the shares of Silva Pharmaceuticals Limited will commence at DSE from today i.e. October 10, 2018 under 'N' category. DSE Trading Code for Silva Pharmaceuticals Limited is "SILVAPHL" and DSE Company Code is 18493.

Previous Next page